Benedict Kaitlin, Gold Jeremy A W, Chiller Tom, Lyman Meghan
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Med Mycol. 2025 Jun 5;63(6). doi: 10.1093/mmy/myaf049.
We conservatively estimated the annual US fungal disease-related economic burden as $19.4 billion, including direct medical costs ($13.4 billion) of hospitalizations (n = 133 555) and outpatient visits (n = 13.4 million), $1.7 billion from absenteeism, and $4.3 billion from deaths (n = 7288). These findings underscore the need for fungal disease surveillance, treatment, and prevention efforts.
我们保守估计,美国每年与真菌病相关的经济负担为194亿美元,其中包括住院治疗(n = 133555例)和门诊就诊(n = 1340万例)的直接医疗费用(134亿美元)、17亿美元的旷工损失以及43亿美元的死亡损失(n = 7288例)。这些发现凸显了真菌病监测、治疗和预防工作的必要性。